An evaluation of human neurophysin production in Alzheimer's disease: Preliminary observations

William G. North, Robert Harbaugh, Teddie Reeder

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The concentrations of human neurophysins in the cerebrospinal fluid (CSF) of nine patients with Alzheimer's disease: Preliminary observations. (AD), and one patients with Pick's disease, were determined using specific radioimmunoassays (RIAs). Concentrations of vasopressin and oxytocin were also measured. Values were compared with those from 20 age-matched mentally normal individuals who were being treated for back pain. CSF levels of vasopressin-associated human neurophysin (VP-HNP) and oxytocin-associated human neurophysin (OT-HNP) in patients with AD (22 ± 4 fmol/ml and 104 ± 17 fmol/ml) were only 42% and 58% of those in the control subjects (p < 0.0001, p < 0.0004). Vasopressin levels for these patients (3.6 ± 0.4 fmol/ml) were also significantly reduced to 51% of controls (p < 0.007) and oxytocin levels were marginally (p = 0.092) reduced to 70% of controls. Because neurophysins and neuropeptides are generelated products of vasopressin-neurons and oxytocin-neurons, the data indicate that these neurons are functionally impaired in patients with AD. Plasma neurophysin values suggest this impairment is confined to neurons with centrally-directed axons. Data from the one patient with Pick's disease demonstrates that reduced CSF levels of neurophysins and hormones is not confined to Alzheimer-type dementia.

Original languageEnglish (US)
Pages (from-to)261-265
Number of pages5
JournalNeurobiology of Aging
Volume13
Issue number2
DOIs
StatePublished - Jan 1 1992

Fingerprint

Neurophysins
Alzheimer Disease
Oxytocin
Vasopressins
Pick Disease of the Brain
Cerebrospinal Fluid
Neurons
Back Pain
Neuropeptides
Radioimmunoassay
Axons
Hormones

All Science Journal Classification (ASJC) codes

  • Neuroscience(all)
  • Aging
  • Clinical Neurology
  • Developmental Biology
  • Geriatrics and Gerontology

Cite this

@article{bb7be887cf594cddbd313df73a7be8f0,
title = "An evaluation of human neurophysin production in Alzheimer's disease: Preliminary observations",
abstract = "The concentrations of human neurophysins in the cerebrospinal fluid (CSF) of nine patients with Alzheimer's disease: Preliminary observations. (AD), and one patients with Pick's disease, were determined using specific radioimmunoassays (RIAs). Concentrations of vasopressin and oxytocin were also measured. Values were compared with those from 20 age-matched mentally normal individuals who were being treated for back pain. CSF levels of vasopressin-associated human neurophysin (VP-HNP) and oxytocin-associated human neurophysin (OT-HNP) in patients with AD (22 ± 4 fmol/ml and 104 ± 17 fmol/ml) were only 42{\%} and 58{\%} of those in the control subjects (p < 0.0001, p < 0.0004). Vasopressin levels for these patients (3.6 ± 0.4 fmol/ml) were also significantly reduced to 51{\%} of controls (p < 0.007) and oxytocin levels were marginally (p = 0.092) reduced to 70{\%} of controls. Because neurophysins and neuropeptides are generelated products of vasopressin-neurons and oxytocin-neurons, the data indicate that these neurons are functionally impaired in patients with AD. Plasma neurophysin values suggest this impairment is confined to neurons with centrally-directed axons. Data from the one patient with Pick's disease demonstrates that reduced CSF levels of neurophysins and hormones is not confined to Alzheimer-type dementia.",
author = "North, {William G.} and Robert Harbaugh and Teddie Reeder",
year = "1992",
month = "1",
day = "1",
doi = "10.1016/0197-4580(92)90038-Y",
language = "English (US)",
volume = "13",
pages = "261--265",
journal = "Neurobiology of Aging",
issn = "0197-4580",
publisher = "Elsevier Inc.",
number = "2",

}

An evaluation of human neurophysin production in Alzheimer's disease : Preliminary observations. / North, William G.; Harbaugh, Robert; Reeder, Teddie.

In: Neurobiology of Aging, Vol. 13, No. 2, 01.01.1992, p. 261-265.

Research output: Contribution to journalArticle

TY - JOUR

T1 - An evaluation of human neurophysin production in Alzheimer's disease

T2 - Preliminary observations

AU - North, William G.

AU - Harbaugh, Robert

AU - Reeder, Teddie

PY - 1992/1/1

Y1 - 1992/1/1

N2 - The concentrations of human neurophysins in the cerebrospinal fluid (CSF) of nine patients with Alzheimer's disease: Preliminary observations. (AD), and one patients with Pick's disease, were determined using specific radioimmunoassays (RIAs). Concentrations of vasopressin and oxytocin were also measured. Values were compared with those from 20 age-matched mentally normal individuals who were being treated for back pain. CSF levels of vasopressin-associated human neurophysin (VP-HNP) and oxytocin-associated human neurophysin (OT-HNP) in patients with AD (22 ± 4 fmol/ml and 104 ± 17 fmol/ml) were only 42% and 58% of those in the control subjects (p < 0.0001, p < 0.0004). Vasopressin levels for these patients (3.6 ± 0.4 fmol/ml) were also significantly reduced to 51% of controls (p < 0.007) and oxytocin levels were marginally (p = 0.092) reduced to 70% of controls. Because neurophysins and neuropeptides are generelated products of vasopressin-neurons and oxytocin-neurons, the data indicate that these neurons are functionally impaired in patients with AD. Plasma neurophysin values suggest this impairment is confined to neurons with centrally-directed axons. Data from the one patient with Pick's disease demonstrates that reduced CSF levels of neurophysins and hormones is not confined to Alzheimer-type dementia.

AB - The concentrations of human neurophysins in the cerebrospinal fluid (CSF) of nine patients with Alzheimer's disease: Preliminary observations. (AD), and one patients with Pick's disease, were determined using specific radioimmunoassays (RIAs). Concentrations of vasopressin and oxytocin were also measured. Values were compared with those from 20 age-matched mentally normal individuals who were being treated for back pain. CSF levels of vasopressin-associated human neurophysin (VP-HNP) and oxytocin-associated human neurophysin (OT-HNP) in patients with AD (22 ± 4 fmol/ml and 104 ± 17 fmol/ml) were only 42% and 58% of those in the control subjects (p < 0.0001, p < 0.0004). Vasopressin levels for these patients (3.6 ± 0.4 fmol/ml) were also significantly reduced to 51% of controls (p < 0.007) and oxytocin levels were marginally (p = 0.092) reduced to 70% of controls. Because neurophysins and neuropeptides are generelated products of vasopressin-neurons and oxytocin-neurons, the data indicate that these neurons are functionally impaired in patients with AD. Plasma neurophysin values suggest this impairment is confined to neurons with centrally-directed axons. Data from the one patient with Pick's disease demonstrates that reduced CSF levels of neurophysins and hormones is not confined to Alzheimer-type dementia.

UR - http://www.scopus.com/inward/record.url?scp=0026604172&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026604172&partnerID=8YFLogxK

U2 - 10.1016/0197-4580(92)90038-Y

DO - 10.1016/0197-4580(92)90038-Y

M3 - Article

C2 - 1522943

AN - SCOPUS:0026604172

VL - 13

SP - 261

EP - 265

JO - Neurobiology of Aging

JF - Neurobiology of Aging

SN - 0197-4580

IS - 2

ER -